News & Events

StageBio to Attend STP 44th Annual Symposium in Chicago, Illinois

Frederick, MD – May 29, 2025: StageBio will be available at booth #115 during this year’s Society of Toxicologic Pathology 44th Annual Symposium.

According to the Society of Toxicologic Pathology, the upcoming symposium topics include “Toxicologic Neuropathology: Basics and Beyond,” with a focus on effective animal to human translation in the development of neurotherapeutics.

StageBio is staffed with a team of 20+ board-certified veterinary pathologists and offers expansive services that include tissue analysis, efficacy determination, and detailed reporting on neuropathology. With the expertise of its staff and the capabilities of its technology, StageBio is uniquely positioned to discuss the latest advances in the development of neurotherapeutics.

The STP 44th Annual Symposium will take place from June 22 to June 25 at Hotel Fairmont at Millennium Park in Chicago, IL. StageBio invites attendees to visit booth #115 and speak with its team of expert pathologists on recent findings, new technologies and other updates in the field of toxicologic neuropathology.

Register for the STP 44th Annual Symposium at toxpath.org/AM2025/registration.asp.

For more information regarding the preclinical and clinical capabilities services of StageBio, contact us at www.stagebio.com/contact

About StageBio

StageBio is a leading provider of GLP-compliant necropsy, histology, pathology and specimen archiving services for the biopharmaceutical, medical device, academic, government and contract research industries. The company operates two GLP laboratories and  a GLP specimen archiving facilities in the U.S. and Europe, with substantial continued investment in facility and technology infrastructure to meet the growing demand for high-quality histopathology services globally. StageBio has a team of 20+ board-certified veterinary pathologists and more than 100 laboratory personnel on staff supporting our unified commitment to quality, scientific integrity and client satisfaction. Learn more at www.stagebio.com.

 

Back to Index

Learn more about StageBio’s COVID-19 response